Sacrosidase

Sacrosidase (trade name Sucraid) is a medication used to replace sucrase in people lacking this enzyme.^[1] It is available as an oral solution. Sucraid is approved by the U.S. Food and Drug Administration (FDA) for the therapy of the genetically determined sucrase deficiency that is part of the Congenital Sucrase-Isomaltase Deficiency (CSID). Sacrosidase assists in the breakdown of sugar/sucrose into simpler forms and is useful for the relief of gastrointestinal symptoms that are associated with CSID.

Sacrosidase

Clinical data
Trade names	Sucraid
AHFS/Drugs.com	Monograph
Routes of administration	Oral
ATC code	A16AB06 (WHO)
Legal status
Legal status	US: ℞-only
Identifiers
CAS Number	85897-35-4 Y
ChemSpider	none
UNII	8A7F670F2Y
ChEMBL	ChEMBL1201487 N
NY (what is this?)  (verify)